Status:
COMPLETED
Metformin Use and Vitamin B12 Deficiency
Lead Sponsor:
Northwell Health
Conditions:
Vitamin B12 Deficiency
Type 2 Diabetes Mellitus
Eligibility:
All Genders
20-80 years
Brief Summary
The primary objective is to determine the incidence of Vitamin B12 deficiency in patients on metformin therapy for diabetes.
Eligibility Criteria
Inclusion
- Age 20-80; diagnosed with type 2 diabetes for at least 30 days
Exclusion
- known vitamin B12 or folate deficiency; pernicious anemia; on vitamin B12 therapy; hematological malignancy; methotrexate use; alcohol intake greater than two drinks per day; vegetarian diet; previous gastric surgery; inflammatory bowel disease
Key Trial Info
Start Date :
August 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
89 Patients enrolled
Trial Details
Trial ID
NCT01136512
Start Date
August 1 2007
End Date
December 1 2008
Last Update
July 31 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Staten Island University Hospital
Staten Island, New York, United States, 10305